Topical Formulation Accelerator
Accelerate topical formulation development with AI-guided ingredient compatibility and regulatory...
What You Can Do
Systematically evaluate ingredient compatibility against your active pharmaceutical ingredients, predict formulation behavior and stability risks, and troubleshoot phase separation, incompatibility, and irritation issues in real time. Generate ICH-aligned stability protocols, excipient safety summaries, and regulatory-ready documentation that accelerates IND, NDA, and ANDA submissions without replacing lab validation.
Features
Rapidly evaluate 50+ excipient combinations against your actives, identifying chemical and physical conflicts before scale-up.
Systematically compare delivery approaches (oil-in-water, silicone-based, occlusive, semi-occlusive) to match your active's physicochemical properties.
Diagnose and resolve common topical issues: phase separation, emulsion instability, irritation potential, and percutaneous penetration problems.
Generate temperature, humidity, and light-stress testing parameters and timelines for regulatory compliance.
Produce excipient safety summaries, formulation rationale documents, and justification narratives ready for submission.
Assess delivery potential based on active molecular weight, lipophilicity, and formulation vehicle properties.
Use validated frameworks to isolate root causes of formulation failures and test targeted solutions systematically.
Example Output
Example 1: Excipient Compatibility Report Active: Retinol (0.5%). Assessment output includes: phase stability predictions for 10 candidate bases (e.g., "Glyceryl Stearate + Stearic Acid: risk of oxidative degradation due to Fe³⁺ catalysis; recommend chelator (disodium EDTA 0.1%)"), irritancy scoring by excipient, emulsification risks, and ranked "Go/No-Go" recommendations.
Example 2: Stability Protocol Generated ICH Zone 2/4 stability testing plan:
- Long-term: 25°C ± 2°C, 60% RH ± 5%, 36 months
- Intermediate: 30°C ± 2°C, 75% RH ± 5%, 12 months
- Accelerated: 40°C ± 2°C, 75% RH ± 5%, 6 months With specific analytical methods (HPLC, viscosity, pH) and acceptance criteria aligned to ICH Q1A.
Example 3: Troubleshooting Output Problem: "Emulsion creams separating after 2 weeks at 25°C." Analysis identifies: inadequate emulsifier concentration (recommend increase from 2% to 3.5%), incompatibility between squalane and proposed gelling agent (recommend alternatives: Carbomer 940 or xanthan gum). Includes 3 reformulation scenarios with predicted outcomes.
What's Included
- SKILL.md instruction file with complete workflow and assessment frameworks:
- Excipient Compatibility Checklist: structured matrix for evaluating 50+ common topical excipients (emollients, humectants, preservatives, thickeners, surfactants)
- ICH Stability Protocol Template: region-specific testing parameters for Zone 2/4 submissions
- Formulation Troubleshooting Flowchart: decision trees for diagnosing phase separation, oxidation, irritation, and incompatibility issues
- Regulatory Documentation Generator: templates for excipient safety narratives, formulation rationale, and submission-ready justification documents
- Percutaneous Penetration Assessment Framework: predictive criteria based on molecular weight, LogP, and delivery vehicle properties
Who It's For
- Formulation Scientists — developing new topical drug products and optimizing ingredient combinations
- R&D Managers — leading formulation projects and needing rapid iteration on development timelines
- Regulatory Affairs Professionals — preparing submission documents and compliance narratives
- Quality Assurance Specialists — designing stability protocols and excipient qualification studies
- Contract Manufacturers — supporting topical drug manufacturing and supplier partnerships
Best For
- Excipient screening and compatibility assessment at project initiation
- Formulation troubleshooting when prototypes show instability, phase separation, or irritation
- Regulatory documentation preparation for IND, NDA, and ANDA submissions
- Stability protocol design aligned with ICH and FDA guidelines
- Comparative formulation strategy evaluation (delivery vehicle selection)
You might also like
This skill systematically analyzes your product designs to identify manufacturability issues early, saving costly revisions and manufacturing delays. It evaluates geometry, material selection, tolerances, assembly feasibility, and production process constraints. You get actionable feedback on cost drivers, process risks, and design optimizations before committing to production.
by kody-w
This skill organizes complex toxicology datasets, clinical adverse events, and mechanistic findings into structured, FDA/EMA-compliant safety narratives. You input raw safety data—adverse event summaries, laboratory results, animal study findings, vital signs—and receive draft safety summaries, detailed safety assessments, and expedited safety reports ready for regulatory submission. It handles IND applications, annual safety updates, clinical development safety overviews, and urgent safety communications with proper MedDRA coding and regulatory formatting.
by kody-w
You can submit tool designs—drawings, specifications, or descriptions—and Claude will evaluate manufacturability constraints, identify potential failure modes using structured frameworks, and recommend cost-reduction opportunities. You'll receive a prioritized report covering structural analysis, production feasibility, material efficiency, and design trade-offs.
by kody-w
You can take unstructured monitoring visit observations and convert them into formal, audit-ready reports that categorize findings by risk level (Critical, Major, Minor), validate protocol compliance, and generate actionable follow-up items with assigned owners and resolution dates. The skill ensures your documentation meets FDA inspection standards and ICH-GCP requirements while creating clear escalation pathways for high-risk issues.
by kody-w
You can automate the validation of clinical trial data against protocol specifications, identify discrepancies including missing values, out-of-range results, protocol violations, and CRF inconsistencies. The skill generates audit-ready query documentation, categorizes anomalies by severity and type, resolves root causes systematically, and produces FDA inspection-ready reports that trace every data decision and corrective action for CDISC and regulatory submission.
by kody-w
You can submit raw mass spectrometry observations, instrument parameters, or sample preparation details to Claude and receive targeted diagnostic frameworks that explain anomalous results. Claude systematically generates plausible mechanistic explanations for unexpected protein abundance patterns, quantification inconsistencies, and PTM findings—then helps you design minimal, hypothesis-driven troubleshooting experiments to test them.
by kody-wThis skill interprets your FEA simulation results and extracts actionable design improvements. You can pinpoint stress concentrations, validate designs against safety factors and material limits, and receive specific geometry recommendations to reduce weight or improve performance. By automating FEA post-processing, you compress design iteration cycles and make engineering decisions faster.
by kody-w
You can analyze equipment sensors, operational logs, and historical maintenance data to predict failures weeks in advance. Claude generates actionable maintenance schedules, identifies high-risk assets, and calculates the financial impact of preventive vs. reactive maintenance. This skill transforms raw operational data into strategic maintenance decisions that minimize downtime and extend asset life.
by kody-w